In our previous study, we have shown that elevated levels of TNF-α in hypertension decreased the amount of Epo in the circulation and that circulating Epo concentrations increased to normal values when TNF-α was blocked with anti-TNF-α antibodies [12]. The gene discussed is EPO; the disease is Hypertension.